Enrollment targets (United States only, international only, international + United States)
| . | Total projected enrollment . |
|---|---|
| Newly diagnosed (n = 17) | |
| Phase 1 | 88 |
| Phase 1/2 | 93 |
| Phase 2 | 948 |
| Phase 2/3 | 540 |
| Phase 3 | 1763 |
| Relapsed/refractory (n = 19) | |
| Phase 1 | 197 |
| Phase 1/2 | 333 |
| Phase 2 | 760 |
| Phase 3 | 1652 |
| . | Total projected enrollment . |
|---|---|
| Newly diagnosed (n = 17) | |
| Phase 1 | 88 |
| Phase 1/2 | 93 |
| Phase 2 | 948 |
| Phase 2/3 | 540 |
| Phase 3 | 1763 |
| Relapsed/refractory (n = 19) | |
| Phase 1 | 197 |
| Phase 1/2 | 333 |
| Phase 2 | 760 |
| Phase 3 | 1652 |